The transcription factor FOXM1 was noted as a downstream target gene of ALKBH5, consistent with previous studies which found FOXM1 to have a critical role in the tumorigenicity of GSCs, in addition to being associated with poor prognosis in GBM patients [61,62]. This evidence concerns the gene ALKBH5 and glioblastoma.